Morocco “was right to maintain the therapeutic protocol based on chloroquine” to treat patients with the new coronavirus (Covid-19), said the Minister of Health, Khalid Ait Taleb.
“The Ministry of Health has a pharmacovigilance report related to the use of chloroquine and which proves that we were right to maintain our decision,” said Ait Taleb, who spoke at a webinar for health professionals and the press.
“At the time when the World Health Organization had called for the suspension of clinical trials on a global level, Morocco remained committed to its initial decision, the relevance of which was demonstrated a few days later”, he argued, explaining that chloroquine “has a very positive effect in the treatment of Covid-19”.
He recalled that “Morocco has known chloroquine for a long time, through its use in internal medicine and for the treatment of malaria”, noting that its undesirable effects “were not a problem, given that they are known and we mastered them perfectly”.
“We are proud of our judicious and forward-looking decisions in terms of therapeutic protocols”, rejoiced the Minister, welcoming the technical and scientific committee “who made very important and very efficient decisions because, by integrating chloroquine in the therapeutic protocol, it allowed us to avoid repercussions for those affected”.
This virtual meeting was held under the theme “How to achieve deconfinement in health and economic terms? The role of the press in raising awareness”, at the initiative of the Moroccan Society for Medical Sciences and the National Health Federation, in collaboration with the Ministry.